Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cancer Invasion/microenvironment Hypoxia HIF

Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)

Price and availability

375 244 ₸

Availability

Order now and get it on Tuesday March 02, 2021

Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EP1215Y] to HIF-1 alpha
  • Suitable for: ICC/IF, Flow Cyt, IP, WB, IHC-P
  • Reacts with: Human

You may also be interested in

Product image
Human HIF1A (HIF-1 alpha) knockout HCT116 cell line (ab255394)
Product image
Anti-HIF-1 alpha antibody [mgc3] (ab16066)
Product image
Anti-HIF-1 alpha antibody [EPR16897] - BSA and Azide free (ab221610)
Product image
Anti-HIF3 alpha/IPAS antibody (ab176464)

Overview

  • Product name

    Anti-HIF-1 alpha antibody [EP1215Y]
    See all HIF-1 alpha primary antibodies
  • Description

    Rabbit monoclonal [EP1215Y] to HIF-1 alpha
  • Host species

    Rabbit
  • Specificity

    ab51608 recognizes HIF-1-alpha. For mouse specific Hif-1-alpha rabbit monoclonal antibody, please see ab179483 (clone ID: EPR16897). ab179483 has been confirmed for mouse samples in WB.
  • Tested Applications & Species

    Application Species
    Flow Cyt
    Human
    ICC/IF
    Human
    IHC-P
    Human
    IP
    Human
    WB
    Human
    See all applications and species data
  • Immunogen

    within Human HIF-1 alpha aa 600-700 (C terminal). The exact sequence is proprietary.
    Database link: Q16665
    (Peptide available as ab205542)

  • Positive control

    • WB: DFO treated HeLa nuclear lysate (ab180880) and Ramos cell lysate treated with Cocl2. IHC-P: Human ovarian carcinoma, breast carcinoma, colonic adenocarcinoma and squamous cell cervical carcinoma tissues. Human gastric cancer tissue. Human CRC tumour tissue. ICC/IF: DFO treated Hela cells, Cocl2 treated HeLa cells and baicalein treated HepG2 cells. Flow Cyt: DFO treated HeLa cells. IP: DFO treated HeLa nuclear lysate.
  • General notes

    For Mouse specific Hif-1-alpha rabbit monoclonal antibody, please see ab179483 (clone ID: EPR16897).

    ab179483 has been confirmed for Mouse sample in WB.

    We have mixed customer feedback towards the rat specificity so we are unable to confirm and guarantee its performance with rat samples. Please contact technical team for more information.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle.
  • Dissociation constant (KD)

    KD = 2.24 x 10 -10 M
    Learn more about KD
  • Storage buffer

    pH: 7.20
    Preservative: 0.01% Sodium azide
    Constituents: 59% PBS, 40% Glycerol, 0.05% BSA
  • Concentration information loading...
  • Purity

    Protein A purified
  • Clonality

    Monoclonal
  • Clone number

    EP1215Y
  • Isotype

    IgG
  • Research areas

    • Cardiovascular
    • Hypoxia
    • HIF
    • Epigenetics and Nuclear Signaling
    • Transcription
    • Domain Families
    • HLH / Leucine Zipper
    • HLH
    • Epigenetics and Nuclear Signaling
    • Cardiovascular/Immune
    • Hypoxia
    • HIF
    • Cancer
    • Invasion/microenvironment
    • Hypoxia
    • HIF
    • Cancer
    • Cancer Metabolism
    • Response to hypoxia
    • Metabolism
    • Pathways and Processes
    • Metabolic signaling pathways
    • Nucleotide metabolism
    • Metabolism
    • Pathways and Processes
    • Metabolism processes
    • Hypoxia
    • Metabolism
    • Types of disease
    • Cancer

Images

  • Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) This image is courtesy of an anonymous Abreview
    All lanes : Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) at 1/2000 dilution

    Lane 1 : MCF-7 (normoxia)
    Lane 2 : MCF-7 treated with 0.5% oxygen for 24 hours

    Lysates/proteins at 30000 cells per lane.

    Secondary
    All lanes : Polyclonal Swine anti-rabbit IgG HRP at 1/1000 dilution

    Predicted band size: 93 kDa



    Blocking buffer: 5% milk for 16 hours at 4°C. 

    See Abreview

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) Zeindl-Eberhart E et al. Epithelial-mesenchymal transition induces endoplasmic-reticulum-stress response in human colorectal tumor cells. PLoS One 9:e87386 (2014).

    Immunohistochemical analysis of Formalin-fixed paraffin-embedded human CRC tumour tissue using ab51608 for HIF-1 alpha staining. Endogenous peroxidase of sections was inhibited by 7.5% H2O2 at room temperature

    In central tumor areas of human CRCs β-catenin was typically localized at the cell membrane (A) whereas only a weak staining was observed for cytoplasmic GRP78 (B) and HIF-1 alpha staining was found to be negative (C). At the invasion front strong nuclear β-catenin was detectable indicating EMT (D, G). In corresponding regions strong cytoplasmic GRP78 expression was found (E, H). In some of the cases an intense nuclear HIF-1 alpha staining was observed (F, with hypoxia), but not in others (I, without hypoxia) (magnification 200×; scale bar: 100 µm).

  • Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)

    ab51608 staining HIF-1-alpha in HeLa cell line treated with Cocl2 by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with 4% Paraformaldehyde permeabilized with 0.1% Triton X-100. Samples were incubated with primary antibody (1/500). An Alexa Fluor® 488-conjugated Goat anti-rabbit IgG(1/200) was used as the secondary antibody. Nuclei were counterstained with DAPI(right hand image).

  • Flow Cytometry - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Flow Cytometry - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)

    Overlay histogram showing HeLa untreated (Blue line) and HeLa treated (Red line - Deferoxamine, 1mM, 24 hours) cells stained with ab51608. The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab51608, 1/11709 dilution) for 30 min at 22ºC. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150081) at 1/2000 dilution for 30 min at 22ºC.

    Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.

  • Immunoprecipitation - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Immunoprecipitation - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)

    HIF-1-alpha was immunoprecipitated using 0.5mg HeLa Nuclear DFO treated whole cell extract (ab180880), 5µg of Rabbit polyclonal to HIF1 alpha and 50µl of protein G magnetic beads (+). No antibody was added to the control (-).

    The antibody was incubated under agitation with Protein G beads for 10min, HeLa DFO treated whole cell extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.

    Proteins were eluted by addition of 40µl SDS loading buffer and incubated for 10min at 70°C; 10µl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with unpurified ab51608.

    Secondary: Mouse monoclonal [SB62a] Secondary Antibody to Rabbit IgG light chain (HRP) (ab99697).

    Band: 110kDa; HIF1 alpha

  • Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)

    HeLa cells were untreated or treated with 1mM Deferoxamine (DFO) for 24h and fixed with paraformaldehyde for imaging by fluorescent microscopy. Cells were blocked and stained with 1X blocking buffer (ab126587). Unpurified ab51608 was used at 1:500. DAPI was used to label the nucleus. HIF1 alpha staining is absent in untreated cells and induced by DFO treatment. HIF1 alpha localizes to the nucleus.

  • Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) at 1/100 dilution + Ramos Cells treated with Cocl2 at 10 µg

    Secondary
    Goat Anti-Rabbit IgG, (H+L), HRP- conjugated at 1/1000 dilution

    Predicted band size: 93 kDa

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)

    ab51608 staining HIF-1-alpha in Human ovarian carcinoma tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed and paraffin-embedded, antigen retrieval was by heat mediation in Tris/EDTA buffer pH9. Samples were incubated with primary antibody (1/100). An undiluted HRP-conjugated anti-rabbit IgG was used as the secondary antibody. Tissue counterstained with Hematoxylin.

  • Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)

    Unpurified ab51608 staining HIF-1-alpha in HepG2 cells treated with baicalein (ab120723), by ICC/IF. Increase in HIF-1-alpha expression correlates with increased concentration of baicalein as described in literature.
    The cells were incubated at 37°C for 6h in media containing different concentrations of ab120723 (baicalein) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab51608 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) Chen L et al. HIF-1 alpha overexpression correlates with poor overall survival and disease-free survival in gastric cancer patients post-gastrectomy. PLoS One 9:e90678 (2014).

    Immunohistochemical analysis of paraffin-embedded formalin-fixed human gastric cancer tissue stained for HIF-1 alpha using ab15608 at 1/600 dilution.  Tissue sections were counterstained with Mayer's hematoxylin. Citrate buffer (pH 6.0) antigen retrieval using standard methodology

    C. HIF-1 alpha was located mainly in the nucleus of tumor cells (positive expression ×400).
    D. HIF-1 alpha original magnification ×100.

  • Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)

    ab51608 staining of HIF-1-alpha in untreated HeLa cell line by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with 4% Paraformaldehyde permeabilized with 0.1% Triton X-100. Samples were incubated with primary antibody (1/500). An Alexa Fluor® 488-conjugated Goat anti-rabbit IgG(1/200) was used as the secondary antibody. Nuclei were counterstained with DAPI(right hand Image).

  • Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)

    Immunohistochemical analysis using unpurified ab51608 showing positive staining in Breast carcinoma tissue.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)

    Immunohistochemical analysis using unpurified ab51608 showing positive staining in Colonic adenocarcinoma tissue. Heat mediated antigen retrieval was performed via the microwave method before commencing with IHC staining protocol.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)

    Immunohistochemical analysis using unpurified ab51608 showing positive staining in Squamous cell cervical carcinoma tissue. Heat mediated antigen retrieval was performed via the microwave method before commencing with IHC staining protocol.

  • Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    All lanes : Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) at 1/2000 dilution (Unpurified)

    Lane 1 : HeLa nuclear extract lysate (ab150036)
    Lane 2 : Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)

    Lysates/proteins at 40 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/10000 dilution

    Developed using the ECL technique.

    Performed under reducing conditions.

    Predicted band size: 93 kDa
    Observed band size: 110 kDa why is the actual band size different from the predicted?


    Exposure time: 8 minutes


    Abcam recommends using 5% milk as the blocking agent, decreasing to 2% milk during primary and secondary incubation. Abcam welcomes customer feedback and would appreciate any comments regarding this product and the data presented above.

  • Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) Image courtesy of Teresa Otto (University of Duisburg-Essen, Germany)

    Anti-HIF-1-alpha unpurified antibody (ab51608) reactivity with reduced Hep3B cell lysate after transient transfection of scrambled siRNA (lanes1-3 and 7-9) or HIF-1-alpha siRNA (lanes 4-6 and 10-12). Cells were incubated at with 21% O2 (lanes 1-6) or 1% O2 (lanes 7-12) for 4h before lysis. After SDS-PAGE, membranes were blocked in 5% milk for 1h at 25°C before incubation with unpurified ab51608 (1/1,000 dilution 5% milk) for 16h at 4ºC. The blot was then incubated with an anti-Rabbit HRP-conjugated secondary antibody before developing with ECL.

    See Abreview

  • Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    All lanes : Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) at 1/2000 dilution (unpurified)

    Lane 1 : HeLa Whole Cell Lysate (untreated, negative control)
    Lane 2 : HeLa DFO treated (0.5mM, 24h) Whole Cell Lysate
    Lane 3 : HeLa Nuclear Cell Lysate (untreated, negative control)
    Lane 4 : HeLa Nuclear DFO treated (0.5mM, 24h) Cell Lysate

    Lysates/proteins at 40 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/10000 dilution

    Performed under reducing conditions.

    Predicted band size: 93 kDa
    Observed band size: 110 kDa why is the actual band size different from the predicted?


    Exposure time: 2 minutes


    Abcam recommends using 5% milk as the blocking agent, decreasing to 2% milk during primary and secondary incubation. Abcam welcomes customer feedback and would appreciate any comments regarding this product and the data presented above.

  • OI-RD Scanning - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    OI-RD Scanning - Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Equilibrium disassociation constant (KD)
    Learn more about KD

    Click here to learn more about KD
  • Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)
    Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-HIF-1 alpha antibody [EP1215Y] (ab51608)

  •  
  • Product image

    Alexa Fluor® 647 Anti-HIF-1 alpha antibody [EPR16897] (ab208420)

    Applications: ICC/IF

  •  
  • Product image

    Anti-HIF-1 alpha antibody [BL-124-3F7] (ab243860)

    Applications: ChIP-seq, ICC, IHC-P, IP, WB

  •  
  • Product image

    Alexa Fluor® 647 Anti-HIF-1 alpha antibody [EP1215Y] (ab190569)

    Applications: ICC/IF

  •  
  • Product image

    Anti-HIF-1 alpha antibody [EPR16897] (ab179483)

    Applications: ICC/IF, WB

  •  
  • Product image

    Anti-HIF-1 alpha antibody - C-terminal (ab228649)

    Applications: ChIP, ICC/IF, IHC-P, IP, WB

  •  
  • Product image

    Alexa Fluor® 647 Anti-HIF-1 alpha antibody [H1alpha67] (ab203848)

    Applications: ICC/IF

  •  
  • Product image

    Anti-HIF-1 alpha antibody [H1alpha67] (ab1)

    Applications: Flow Cyt, ICC/IF, IP, WB

  •  
  • Product image

    Anti-HIF-1 alpha antibody [EP1215Y] - BSA and Azide free (ab210073)

    Applications: Flow Cyt, ICC, IHC-P, IP, WB

  •  
  • Product image

    Anti-HIF-1 alpha antibody [EPR16897] - BSA and Azide free (ab221610)

    Applications: ICC/IF, WB

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.